Dear Sirs,
A 42-year-old man of Polish extraction presented with a four year history of slowly deteriorating reading difficulties and gait imbalance. There was no evidence for alcohol or recreational substance abuse. Family history was unremarkable.
On examination he had tandem gait ataxia. Power was normal and with no atrophies. Deep tendon reflexes were pronounced on the left with ipsilaterally extensor plantar response. He had upper limb past pointing, pronounced on the left.
Visual acuity was 20/60 on the right and 20/80 on the left. Colour vision (Ishihara plates): 13/15 on the right and 10/15 on the left. Humphrey 10:2 perimetry showed reduced sensitivity paracentrally in both eyes. Retinae appeared normal, however both optic discs showed temporal wedge-shaped pallor (Fig. 1) . Examination of extraocular movements was supported by binocular 3D video oculography (video 1). Pendular torsional nystagmus in primary gaze was detected, partly attenuated on left gaze. The nystagmus had two components, a baseline, low amplitude (1°-2°), symmetrical, pendular, torsional oscillation (1.7-2 Hz), and an irregular larger amplitude (2°-5°) nystagmus beating clockwise from the observer's point of view. Both nystagmus components were pronounced in the right eye. The torsional faster component included a large upwards component in the right eye ('left pendular hemiseesaw nystagmus') [1] (Fig. 1) . Non-periodic tremor (2 Hz) of the soft palate and posterior pharyngeal wall muscles was evident (video 2).
Optical coherence tomography of the peripapillary retinal nerve fibre layer confirmed bilateral segmental optic atrophy ( Fig. 1 ). Full-field and multifocal electroretinograms were normal. Amplitudes of pattern reversal visual evoked potentials were bilaterally borderline reduced.
Haematology and biochemistry indices were normal as were vitamin B 12 , folic acid, thyroid function, syphilis and HIV 1/2 serology, and screening for onconeuronal and other auto-antibodies. Cerebrospinal fluid analysis was normal. Full GFAP gene sequencing failed to support the presence of Alexander's disease [2] . Search for spinocerebellar ataxia expansions and/or duplications 1-3, 6, 7, 12 and 20 was negative [3, 4] as were searches for mitochondrial mutations associated with (1) Leber's hereditary optic atrophy [5] , (2) mitochondrial encephalomyopathy,lactic acidosis and stroke-like episodes, (3) myoclonic epilepsy with ragged red fibers, and (4) neuropathy, ataxia and retinitis pigmentosa. Genetic testing for optic atrophy 1 [6] and polymerase gamma gene mutations [7, 8] was also negative.
The MRI head and spinal cord showed a hyper-intense signal in the medulla oblongata on T 2 weighted images suggesting bilateral pseudo-hypertrophy of inferior olivary nuclei, and mild cerebellar atrophy. The MRI of the optic nerves suggested reduced optic nerve diameter, pronounced on the left (Fig. 1) .
To the best of our knowledge sporadic Progressive Ataxia Palatal Tremor (sPAPT) with bilateral optic atrophy and upper motor neuron (UMN) signs has never been reported.
The PAPT is a rare syndrome. sPAPT as well as familial (fPAPT) forms have been described. Whilst sPAPT is typically associated with bilateral pseudo-hypertrophy of the inferior olive and progressive cerebellar atrophy, people with fPAPT show brainstem and spinal cord atrophy in the absence of olivary changes. The fPAPT is often associated with UMN signs whereas cases of sPAPT are associated with cerebellar ataxia [9] . Palatal tremor in sPAPT is characterised by non-periodic, low frequency oscillations (1-3 Hz) of the posterior soft palate, often accompanied by branchial (60 %) and/or ocular (30 %) muscle oscillations [10] . In our case palatal tremor was accompanied by oscillations of branchial as well as ocular muscles to produce left 'pendular hemi-seeshaw' nystagmus. Symptoms and signs were in line with lesions in the medulla oblongata and an ocular degenerative abnormality, respectively [1] . An association between sPAPT and well described neurodegenerative diseases, for example, multiple system atrophy (MSA) has previously been reported [9] . However, early onset, fairly benign course, and lack of clinical and MRI findings characteristic of alternative neurodegenerative diseases render such association in our patient highly unlikely. Thus, in the absence of clinical imaging or laboratory findings supporting the diagnosis of a known cause of PAPT, it is possible that our case represents a novel phenotype of sPAPT with bilateral optic atrophy.
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